Roche Holding AG (RHHBY) Q4 2024 Earnings Call & Full Presentation скачать в хорошем качестве

Roche Holding AG (RHHBY) Q4 2024 Earnings Call & Full Presentation

📢 Roche Holding AG (RHHBY) Q4 2024 Earnings Call & Presentation Join us as Roche's leadership discusses the fourth quarter and full-year 2024 financial performance. This session includes the full official presentation, providing a comprehensive overview of the company's results and strategic initiatives. 🔑 Key Highlights Include: *Financial Performance:* *Group Sales:* Increased by 7% in 2024, with the base business (excluding COVID-19) growing by 9%. *Pharmaceuticals Division:* Achieved a 9% sales growth, driven by strong demand for new medicines. *Diagnostics Division:* Reported an 8% increase in sales, reflecting robust performance across all regions. *Operational Highlights:* *Innovation:* Launched multiple new products and received approvals for key therapies in major markets. *Pipeline Development:* Advanced several promising candidates into late-stage clinical trials. *Global Reach:* Expanded presence in emerging markets, contributing to overall sales growth. *Strategic Initiatives:* *Sustainability Commitment:* Emphasized dedication to environmental and social governance, with initiatives aimed at reducing carbon footprint and enhancing access to healthcare. *Future Outlook:* Provided guidance for 2025, anticipating continued growth driven by innovative product launches and strategic investments. Whether you're an investor, industry analyst, or interested in the healthcare and pharmaceuticals sector, this presentation offers valuable insights into Roche's performance and strategic direction. 📊 Subscribe for more earnings calls and presentations from leading companies each quarter! Don't forget to like, comment, and share your thoughts below.